Frontlight ResearchEarly access
Trial site
Shanghai Pudong Hospital
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Colorectal cancer2 trials
- Type 2 diabetes2 trials
- Acute myeloid leukaemia1 trial
- Alzheimer disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Hepatitis B1 trial
- Mild cognitive impairment1 trial
- Pancreatic cancer1 trial
- Stroke1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Shanghai Pudong Hospital4 trials
- Base Therapeutics (Shanghai) Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Hoffmann-La Roche1 trial
- and 1 more
Running trials
Not yet recruiting
Not yet recruiting
Active, not recruiting
Wearable NH₃ Sensor for Remote Non-invasive Monitoring and Diagnosis of Diabetic Kidney Disease
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hepatitis B1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026